129 related articles for article (PubMed ID: 26317697)
21. Reliability of the gamma index analysis as a verification method of volumetric modulated arc therapy plans.
Park JM; Kim JI; Park SY; Oh DH; Kim ST
Radiat Oncol; 2018 Sep; 13(1):175. PubMed ID: 30217163
[TBL] [Abstract][Full Text] [Related]
22. Correlation analysis between 2D and quasi-3D gamma evaluations for both intensity-modulated radiation therapy and volumetric modulated arc therapy.
Kim JI; Choi CH; Wu HG; Kim JH; Kim K; Park JM
Oncotarget; 2017 Jan; 8(3):5449-5459. PubMed ID: 27690300
[TBL] [Abstract][Full Text] [Related]
23. Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases.
Cilla S; Deodato F; Digesù C; Macchia G; Picardi V; Ferro M; Sallustio G; De Spirito M; Piermattei A; Morganti AG
Med Dosim; 2014; 39(1):108-16. PubMed ID: 24342167
[TBL] [Abstract][Full Text] [Related]
24. Moving GPU-OpenCL-based Monte Carlo dose calculation toward clinical use: Automatic beam commissioning and source sampling for treatment plan dose calculation.
Tian Z; Li Y; Hassan-Rezaeian N; Jiang SB; Jia X
J Appl Clin Med Phys; 2017 Mar; 18(2):69-84. PubMed ID: 28300376
[TBL] [Abstract][Full Text] [Related]
25. Comparison of DVH-based plan verification methods for VMAT: ArcCHECK-3DVH system and dynalog-based dose reconstruction.
Saito M; Kadoya N; Sato K; Ito K; Dobashi S; Takeda K; Onishi H; Jingu K
J Appl Clin Med Phys; 2017 Jul; 18(4):206-214. PubMed ID: 28649722
[TBL] [Abstract][Full Text] [Related]
26. Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases.
Zhang P; Happersett L; Hunt M; Jackson A; Zelefsky M; Mageras G
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1456-62. PubMed ID: 19540062
[TBL] [Abstract][Full Text] [Related]
27. VMATc: VMAT with constant gantry speed and dose rate.
Peng F; Jiang SB; Romeijn HE; Epelman MA
Phys Med Biol; 2015 Apr; 60(7):2955-79. PubMed ID: 25789937
[TBL] [Abstract][Full Text] [Related]
28. Quantification of residual dose estimation error on log file-based patient dose calculation.
Katsuta Y; Kadoya N; Fujita Y; Shimizu E; Matsunaga K; Matsushita H; Majima K; Jingu K
Phys Med; 2016 May; 32(5):701-5. PubMed ID: 27162084
[TBL] [Abstract][Full Text] [Related]
29. Continuous aperture dose calculation and optimization for volumetric modulated arc therapy.
Christiansen E; Heath E; Xu T
Phys Med Biol; 2018 Oct; 63(21):21NT01. PubMed ID: 30362464
[TBL] [Abstract][Full Text] [Related]
30. Impact of small MU/segment and dose rate on delivery accuracy of volumetric-modulated arc therapy (VMAT).
Huang L; Zhuang T; Mastroianni A; Djemil T; Cui T; Xia P
J Appl Clin Med Phys; 2016 May; 17(3):203-210. PubMed ID: 27167278
[TBL] [Abstract][Full Text] [Related]
31. An algorithm to calculate a collapsed arc dose matrix in volumetric modulated arc therapy.
Arumugam S; Xing A; Jameson M; Holloway L
Med Phys; 2013 Jul; 40(7):071724. PubMed ID: 23822428
[TBL] [Abstract][Full Text] [Related]
32. Monitoring of mechanical errors and their dosimetric impact throughout the course of non-coplanar continuous volumetric-modulated arc therapy.
Hirashima H; Nakamura M; Miyabe Y; Uto M; Nakamura K; Mizowaki T
Radiat Oncol; 2018 Feb; 13(1):27. PubMed ID: 29444693
[TBL] [Abstract][Full Text] [Related]
33. Angular under-sampling effect on VMAT dose calculation: An analysis and a solution strategy.
Park JY; Li F; Li J; Kahler D; Park JC; Yan G; Liu C; Lu B
Med Phys; 2017 Jun; 44(6):2096-2114. PubMed ID: 28370002
[TBL] [Abstract][Full Text] [Related]
34. Dynamic collimator angle adjustments during volumetric modulated arc therapy to account for prostate rotations.
de Boer J; Wolf AL; Szeto YZ; van Herk M; Sonke JJ
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1009-16. PubMed ID: 25618782
[TBL] [Abstract][Full Text] [Related]
35. Accuracy of one algorithm used to modify a planned DVH with data from actual dose delivery.
Ma T; Podgorsak MB; Kumaraswamy LK
J Appl Clin Med Phys; 2016 Sep; 17(5):273-282. PubMed ID: 27685140
[TBL] [Abstract][Full Text] [Related]
36. Multi-institutional comparison of computer-based independent dose calculation for intensity modulated radiation therapy and volumetric modulated arc therapy.
Kamima T; Baba H; Takahashi R; Yamashita M; Sugawara Y; Kawai D; Yamamoto T; Satou A; Tachibana H
Phys Med; 2018 Jan; 45():72-81. PubMed ID: 29472094
[TBL] [Abstract][Full Text] [Related]
37. Variations in dosimetric distribution and plan complexity with collimator angles in hypofractionated volumetric arc radiotherapy for treating prostate cancer.
Li MH; Huang SF; Chang CC; Lin JC; Tsai JT
J Appl Clin Med Phys; 2018 Mar; 19(2):93-102. PubMed ID: 29322625
[TBL] [Abstract][Full Text] [Related]
38. Correlation Between Average Segment Width and Gamma Passing Rate as a Function of MLC Position Error in Volumetric Modulated Arc Therapy.
Moon YM; Bae SI; Han MJ; Jeon W; Yu T; Choi CW; Kim JY
Technol Cancer Res Treat; 2021; 20():15330338211059937. PubMed ID: 34821195
[TBL] [Abstract][Full Text] [Related]
39. Single Arc Volumetric Modulated Arc Therapy of head and neck cancer.
Bertelsen A; Hansen CR; Johansen J; Brink C
Radiother Oncol; 2010 May; 95(2):142-8. PubMed ID: 20188427
[TBL] [Abstract][Full Text] [Related]
40. Assessing dose rate distributions in VMAT plans.
Mackeprang PH; Volken W; Terribilini D; Frauchiger D; Zaugg K; Aebersold DM; Fix MK; Manser P
Phys Med Biol; 2016 Apr; 61(8):3208-21. PubMed ID: 27025897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
